Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney DiNardo

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutationCourtney DiNardo
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
Highlights in acute myeloid leukemia from the 2017 American Society of Hematology Annual Meeting and Exposition: commentaryCourtney DiNardo
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Hereditary Hematologic MalignanciesCourtney DiNardo
Current Hematologic Malignancy Reports|July 28, 2019
Acute Myeloid Leukemia: from Mutation Profiling to Treatment DecisionsCourtney DiNardo, Curtis Lachowiez
Blood and Lymphatic Cancer : Targets and Therapy|July 9, 2025
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]Amer M Zeidan, Courtney DiNardo
Leukemia & Lymphoma|July 18, 2023
<i>IDH2</i> mutations in acute myeloid leukemiaRodrick Babakhanlou, Courtney DiNardo, Gautam Borthakur
Best Practice & Research. Clinical Haematology|June 18, 2019
Venetoclax-based therapies for acute myeloid leukemiaVeronica A Guerra, Courtney DiNardo, Marina Konopleva
Clinical Lymphoma, Myeloma & Leukemia|October 4, 2021
SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Enasidenib for patients with relapsed acute myeloid leukemia and the IDH2 mutationCourtney DiNardo
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
Highlights in acute myeloid leukemia from the 2017 American Society of Hematology Annual Meeting and Exposition: commentaryCourtney DiNardo
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Hereditary Hematologic MalignanciesCourtney DiNardo
Current Hematologic Malignancy Reports|July 28, 2019
Acute Myeloid Leukemia: from Mutation Profiling to Treatment DecisionsCourtney DiNardo, Curtis Lachowiez
Blood and Lymphatic Cancer : Targets and Therapy|July 9, 2025
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]Amer M Zeidan, Courtney DiNardo
Leukemia & Lymphoma|July 18, 2023
<i>IDH2</i> mutations in acute myeloid leukemiaRodrick Babakhanlou, Courtney DiNardo, Gautam Borthakur
Best Practice & Research. Clinical Haematology|June 18, 2019
Venetoclax-based therapies for acute myeloid leukemiaVeronica A Guerra, Courtney DiNardo, Marina Konopleva
Clinical Lymphoma, Myeloma & Leukemia|October 4, 2021
SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Harnessing Apoptosis in AMLKapil Saxena, Courtney DiNardo, Naval Daver, et al.
Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.
Pageof 14